Cadence Pharmaceuticals Inc.

Company Website

12481 High Bluff Dr. Ste., 200
San Diego, CA 92130

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

Cadence Pharmaceuticals Inc.

Market Cap as of 6/12/2015

Market Cap as of 7/03/2014

Market Cap as of 07/02/2013

$590,315,430

Market Cap as of 06/26/2012

$273,299,072

Market Cap as of 01/04/2012

$325,505,200

Market Cap as of 06/20/2011

$577,703,800

Market Cap as of 01/06/2011

$469,837,400

Exchange and Ticker Symbol

Nasdaq: CADX

Fields of Research

Focuses on acquiring, in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting in the United States and Canada

Major Products

Ofirmev

View all the companies in San Diego Publicly Traded Companies

Cadence Pharmaceuticals Inc.

Market Cap as of 6/12/2015

Exchange

NASDAQ GM

Ticker

CADX

Executives

Theodore Schroeder

  • Chief Executive Officer
  • President